Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
33.75 -0.50  -1.46% NASDAQ Jun 22, 20:00 Delayed 2m USD

Pacira Pharmaceuticals Enterprise Value:

1.335B for June 21, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Pacira Pharmaceuticals Enterprise Value Chart

Export Data
Save Image
Print Image

Pacira Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 2011. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 21, 2018 1.335B
June 20, 2018 1.561B
June 19, 2018 1.490B
June 18, 2018 1.455B
June 15, 2018 1.474B
June 14, 2018 1.506B
June 13, 2018 1.502B
June 12, 2018 1.508B
June 11, 2018 1.478B
June 8, 2018 1.455B
June 7, 2018 1.425B
June 6, 2018 1.468B
June 5, 2018 1.376B
June 4, 2018 1.325B
June 1, 2018 1.325B
May 31, 2018 1.335B
May 30, 2018 1.374B
May 29, 2018 1.374B
May 25, 2018 1.388B
May 24, 2018 1.380B
May 23, 2018 1.364B
May 22, 2018 1.327B
May 21, 2018 1.331B
May 18, 2018 1.362B
May 17, 2018 1.362B
   
May 16, 2018 1.350B
May 15, 2018 1.309B
May 14, 2018 1.358B
May 11, 2018 1.345B
May 10, 2018 1.339B
May 9, 2018 1.337B
May 8, 2018 1.276B
May 7, 2018 1.309B
May 4, 2018 1.323B
May 3, 2018 1.288B
May 2, 2018 1.340B
May 1, 2018 1.325B
April 30, 2018 1.288B
April 27, 2018 1.311B
April 26, 2018 1.343B
April 25, 2018 1.345B
April 24, 2018 1.378B
April 23, 2018 1.382B
April 20, 2018 1.406B
April 19, 2018 1.384B
April 18, 2018 1.394B
April 17, 2018 1.390B
April 16, 2018 1.396B
April 13, 2018 1.302B
April 12, 2018 1.347B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

PCRX Enterprise Value Benchmarks

Benchmarks
The Medicines 3.109B
Sage Therapeutics 6.417B
Enanta Pharmaceuticals 2.036B

PCRX Enterprise Value Range, Past 5 Years

Minimum 889.12M Jun 25 2013
Maximum 4.268B Feb 25 2015
Average 2.056B

PCRX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PCRX", "enterprise_value")
  • Last 5 data points: =YCS("PCRX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.